Sueda S, Mineoi K, Kondo T, Yano K, Ochi T, Ochi N, Fukuda H, Kukita H, Kawada H, Matsuda S, Uraoka T
Department of Cardiology, Takanoko Hospital, Ehime.
J Cardiol. 1998 Sep;32(3):155-61.
This study investigated whether the maximal dose of 50 micrograms acetylcholine for the induction of coronary spasm in the right coronary artery is adequate. The acetylcholine test was performed in 388 consecutive patients to evaluate spasm from January 1994 to December 1997. Coronary spasm in the right coronary artery was induced in 43 patients, 37 men and 6 women with a mean age of 63 +/- 8 years by intracoronary injection of 80 micrograms of acetylcholine rather than 50 micrograms. These included 15 patients (35%) with rest angina, 23 patients with ischemic heart disease other than rest angina and 5 patients (12%) with non-ischemic heart disease. Acetylcholine was injected in incremental doses of 20, 50 and 80 micrograms into the right coronary artery. Positive spasm was defined as induction of more than 90% reversible narrowing associated with either usual chest pain or ischemic electrocardiographic changes. Clinical and angiographical characteristics was studied in these patients. Fifteen (35%) patients had rest angina and 4 patients had variant angina with ST elevation in the inferior leads. Two thirds of the patients had coronary spasm in the distal portion of the right coronary artery and one third of those disclosed spasm focally. Coronary spasm was induced in 38 (15%) of 246 patients with ischemic heart disease and in 5 (4%) of 142 patients with non-ischemic heart disease. The prevalence of positive spasm in patients with ischemic heart disease was significantly higher (p < 0.01) than in patients with non-ischemic heart disease. A dose of 80 micrograms of acetylcholine, more than the maximal standard dose, might be clinically useful for the induction of spasm in the right coronary artery if coronary spasm of this artery is strongly suspected.
本研究调查了用于诱发右冠状动脉痉挛的50微克乙酰胆碱最大剂量是否足够。1994年1月至1997年12月,对388例连续患者进行了乙酰胆碱试验以评估痉挛情况。通过冠状动脉内注射80微克而非50微克乙酰胆碱,在43例患者(37例男性和6例女性,平均年龄63±8岁)中诱发了右冠状动脉痉挛。这些患者包括15例(35%)静息性心绞痛患者、23例非静息性心绞痛的缺血性心脏病患者和5例(12%)非缺血性心脏病患者。将20、50和80微克递增剂量的乙酰胆碱注入右冠状动脉。阳性痉挛定义为诱发超过90%的可逆性狭窄,并伴有典型胸痛或缺血性心电图改变。对这些患者的临床和血管造影特征进行了研究。15例(35%)患者有静息性心绞痛,4例患者在下壁导联出现ST段抬高的变异型心绞痛。三分之二的患者右冠状动脉远端发生痉挛,三分之一的患者为局灶性痉挛。246例缺血性心脏病患者中有38例(15%)诱发了冠状动脉痉挛,142例非缺血性心脏病患者中有5例(4%)诱发了冠状动脉痉挛。缺血性心脏病患者中阳性痉挛的发生率显著高于非缺血性心脏病患者(p<0.01)。如果强烈怀疑该动脉存在冠状动脉痉挛,80微克乙酰胆碱剂量超过最大标准剂量,在临床上可能有助于诱发右冠状动脉痉挛。